Exposure-Response FDA Guidance (Ep. 10)

Exposure-Response FDA Guidance (Ep. 10)

This episode is a discussion of the FDA guidance “Exposure-Response Relationships”. The relationship between drug exposure and response is critical to any determination of the safety and effectiveness of a drug product. In this episode I discuss the regulatory applications of exposure-response, the exposure-response relationships over time, the design of studies to collection exposure-response information, and modeling exposure-response relationships. Links discussed in the show: • FDA guidance “Exposure-Response Relationships”ICH E4 guideline “Dose-Response Information” • You can connect with me on LinkedIn and send me a message • Send me a messageSign up for my newsletter Copyright Teuscher Solutions LLC All Rights Reserved


Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(58)

Beyond Small Molecules—Allometric Scaling for Biologics and Engineered mAbs (Ep. 58)

Beyond Small Molecules—Allometric Scaling for Biologics and Engineered mAbs (Ep. 58)

Today’s episode is about allometric scaling with therapeutic antibodies. I discuss differences from small molecules, how to handle antibodies with engineered Fc regions (e.g. YTE or LS), and using all...

27 Jul 0s

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

In this episode I discuss bioequivalence testing and how it was developed to support generic drug approvals, but is now a mainstream tool for all of drug development. I discuss the basics of what bioe...

25 Mai 24min

Examining Volume of Distribution (Ep. 56)

Examining Volume of Distribution (Ep. 56)

In this episode we’re going to define Volume of Distribution, look at the different types of Volume of Distribution parameters, talk about how we actually calculate it, examine what drives its value, ...

20 Apr 19min

Talking about data science with Mike Stackhouse (Ep. 55)

Talking about data science with Mike Stackhouse (Ep. 55)

This episode is an interview with Michael Stackhouse, the Chief Innovation Officer at Atorus Research. We discussed a variety of topics such as modern data science tools, why regulatory agencies want ...

16 Mar 45min

Using Accelerator Mass Spectrometry in Clinical Pharmacology

Using Accelerator Mass Spectrometry in Clinical Pharmacology

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism ...

16 Feb 38min

Using AI tools for regulatory intelligence (Ep. 53)

Using AI tools for regulatory intelligence (Ep. 53)

This episode is an interview with Aruna Dhontabhaktuni, Founder and CEO of RegKey, a regulatory intelligence platform that uses AI. The discussion touches on how companies can leverage large language ...

19 Jan 21min

When to use model-informed drug development (Ep. 52)

When to use model-informed drug development (Ep. 52)

This episode is a collection of my thoughts on model-informed drug development and where different modeling modalities fit into the development schedule. These are just my opinions and each developmen...

22 Des 202528min

QSP Modeling with Ahmed Elmokadem (Ep. 51)

QSP Modeling with Ahmed Elmokadem (Ep. 51)

In this episode I chat with Ahmed Elmokadem about QSP modeling. Ahmed, from Metrum Research Group, is an expert consultant in QSP modeling and how it can be used to provide a framework to connect mech...

24 Nov 202544min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
forskningno
jss
liberal-halvtime
rekommandert
sinnsyn
villmarksliv
dekodet-2
rss-nysgjerrige-norge
abels-tarn
tomprat-med-gunnar-tjomlid
fjellsportpodden
mer-enn-hjerne
hva-er-greia-med
rss-inn-til-kjernen-med-sunniva-rose
diagnose
rss-rekommandert
kvinnehelsepodden
vett-og-vitenskap-med-gaute-einevoll